TUMIATTI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 6.557
AS - Asia 5.901
EU - Europa 5.330
AF - Africa 453
Continente sconosciuto - Info sul continente non disponibili 343
SA - Sud America 290
OC - Oceania 6
Totale 18.880
Nazione #
US - Stati Uniti d'America 6.435
IT - Italia 1.916
VN - Vietnam 1.622
CN - Cina 1.559
SG - Singapore 1.459
GB - Regno Unito 981
DE - Germania 508
HK - Hong Kong 444
SE - Svezia 423
UA - Ucraina 295
FR - Francia 287
IN - India 260
RU - Federazione Russa 227
BR - Brasile 186
CI - Costa d'Avorio 156
IE - Irlanda 136
NL - Olanda 132
TG - Togo 106
JP - Giappone 104
KR - Corea 100
ZA - Sudafrica 88
FI - Finlandia 77
BD - Bangladesh 73
EE - Estonia 73
CA - Canada 68
BG - Bulgaria 46
SC - Seychelles 42
ES - Italia 35
PH - Filippine 35
JO - Giordania 33
AR - Argentina 31
ID - Indonesia 31
MX - Messico 31
TH - Thailandia 31
PL - Polonia 29
TR - Turchia 29
BE - Belgio 27
EC - Ecuador 27
TW - Taiwan 27
HR - Croazia 24
CH - Svizzera 20
GR - Grecia 17
IQ - Iraq 17
PK - Pakistan 14
AT - Austria 13
CO - Colombia 12
IR - Iran 11
MA - Marocco 11
CL - Cile 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
NG - Nigeria 10
CR - Costa Rica 9
EG - Egitto 9
SA - Arabia Saudita 9
LB - Libano 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
PE - Perù 6
PY - Paraguay 6
VE - Venezuela 6
DZ - Algeria 5
ET - Etiopia 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
MT - Malta 4
PT - Portogallo 4
UZ - Uzbekistan 4
BO - Bolivia 3
JM - Giamaica 3
KE - Kenya 3
LK - Sri Lanka 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
KZ - Kazakistan 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SM - San Marino 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
FK - Isole Falkland (Malvinas) 1
Totale 18.525
Città #
Singapore 986
Southend 849
Ashburn 599
Fairfield 533
San Jose 448
Hong Kong 416
Ho Chi Minh City 410
Hanoi 383
Chandler 378
Santa Clara 372
Houston 267
Bologna 252
Woodbridge 243
Wilmington 237
Seattle 226
Beijing 208
Princeton 203
Ann Arbor 199
Jacksonville 199
Hefei 197
Cambridge 178
Council Bluffs 168
Abidjan 156
Boardman 148
Dublin 136
Los Angeles 116
Lomé 106
Padova 96
Lauterbourg 92
Nanjing 91
Milan 88
Westminster 87
New York 84
Dallas 80
Seoul 78
Tokyo 77
Rome 75
Haiphong 63
Helsinki 60
Jinan 58
Berlin 57
Da Nang 56
Dong Ket 52
Buffalo 51
Shenyang 48
Saint Petersburg 45
Sofia 45
Guangzhou 43
Medford 42
Redmond 41
Munich 40
Shanghai 40
Cesena 38
Changsha 38
Turin 37
Hebei 36
Amman 33
Mülheim 33
Tianjin 31
Nanchang 30
San Diego 30
São Paulo 30
Biên Hòa 29
Naples 27
Chicago 26
Palermo 26
Redondo Beach 26
Hải Dương 25
Rimini 25
Yubileyny 25
Brussels 24
Frankfurt am Main 24
Redwood City 24
Falls Church 23
San Giorgio di Piano 23
Forlì 22
Mahé 22
Bengaluru 21
Carpi 21
Haikou 21
Hangzhou 21
Phoenix 21
London 20
Zhengzhou 20
Taiyuan 19
Toronto 19
Bari 18
Bremen 18
Can Tho 18
Des Moines 18
Genoa 18
San Francisco 18
Bến Tre 17
Warsaw 17
Florence 16
Jiaxing 16
Nha Trang 16
Orem 16
Ravenna 16
Amsterdam 15
Totale 11.329
Nome #
Trasportatori di membrana dei farmaci 909
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 431
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 414
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 352
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 303
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 300
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 289
Progettazione e sintesi di analoghi rigidi di metoctramina nello studio dei recettori muscarinici 240
Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR Studies 236
Cytotoxicity of methoctramine and methoctramine-related polyamines. 234
Progettazione e sintesi di poliammine a potenziale attività antitumorale 231
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SUSTITUTED NAPHTHALENE IMIDES AND DIIMIDES AS ANTICANCER AGENT 229
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 226
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 226
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 210
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 205
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 197
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents 196
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors 188
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 187
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 187
Natural polyamines and synthetic analogs modify the growth and the morphology of Pyrus communis pollen tubes affecting ROS levels and causing cell death 182
Study of the cytotoxic effects of the new synthetic isothiocyanate CM9 and its fullerene derivative on human T-leukemia cells 181
Design, Synthesis, and biological evaluation of naphtalene diimides derivatives as anticancer agent 179
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 177
Synthetic polyamines activating autophagy: Effects on cancer cell death 175
NEWLY SYNTHESIZED POLYAMINE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS 173
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and a perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 172
Exploiting RNA as a new biomolecular target for synthetic polyamines 172
Macrocyclic naphthalene diimides as G-quadruplex binders 171
Design, synthesis, and biological evaluation of substituted naphtalene imides and diimides as anticancer agents 169
Phenolic and Antioxidant Characterization of Fruit By-Products for Their Nutraceuticals and Dietary Supplements Valorization under a Circular Bio-Economy Approach 168
Exploring the effects of isothiocyanates on chemotherapeutic drugs 167
Multitarget-directed ligands: Innovative chemical probes and therapeutic tools against Alzheimer's disease 167
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 166
Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent 164
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 163
Synthesis of Monomeric Derivatives To Probe Memoquin's Bivalent Interactions 159
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 159
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines 158
Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update 158
Cytotoxicity of Methoctramine and related Spermine analogues 154
Multifunctional Tacrine Derivatives in Alzheimer’s Disease 154
Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment 154
Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations 154
Preliminary evaluation of the cytotoxicity of naphthalene diimide-polyamine conjugates in human cancer cells 153
One-molecule-multiple-target strategy: a novel multifunctional molecule designed to block EGF-r and to exert pro-apoptotic effects 152
Heterocyclic inhibitors of AChE acylation and peripheral sites. 151
Integrated analytical approaches for the characterization of nutraceutical bioactives in microalgae 150
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 149
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects 148
Progress in acetylcholinesterase inhibitors for Alzheimer's disease 146
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: Effect of replacing the inner polymethylene chain with cyclic moieties 146
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond 144
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers 144
Analytical characterization of commercial microalgae 143
Multi-Target-Direcetd Ligands as acetylcholinesterase inhibitors and nicotinic modulators for Alzheimer's disease 142
Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Futher Investigation on the Inner Spacer. 142
null 141
Polymethylene tetraamine backbone as template for the development of biologically active polyamines 140
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study. 140
Cytotoxicity of methoctramine-related polyamines 139
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains 139
Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors 138
Methoctramine-related polyamines as antinociceptive agents 137
Structure-Activity Relationships of New Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone 136
Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons 136
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases 136
null 135
A rational design of new multi-target-directed-ligands for the treatment of Alzheimer's disease 134
Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agents. 134
Design of Experiments and Optimization of Monacolin K Green Extraction from Red Yeast Rice by Ultra-High-Performance Liquid Chromatography 133
Methoctramine analogues inhibit responses to capsaicin in DRG neurons and cloned TRPV1 133
From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease 133
Inibitori delle fosfodiesterasi 133
Discovery of multipotent drugs for the teratment of Alzheimer's disease 133
Rational design of multitarget-directed antioxidants: merging memoquin and lipocrine molecular frameworks 132
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy 132
Synthetic polyamines: an overview of their multiple biological activities. 129
Multi-Target-Directed Drug Design Strategy: Development of new Naphthalene Diimides Bearing Isothiocyanate Functionality As Anticancer Agents 128
Polyamines analogs and transglutaminase effects on apical growth of the pollen tube 127
Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality 122
Effect of polyamines on the nicotinic ACh receptor 122
Tacrine Derivatives and Alzheimer's Disease 121
Synthetic polyamines as potential amine oxidases inhibitors: a preliminary study 120
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration 118
Methoctramine effects on nicotinic acetylcholine receptor kinetics 115
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. 115
Methoctramine analogues inhibit capsaicin induced currents in dorsal root ganglia and Xenopus oocytes expressing TRPV1 114
Polyamines, their analogs, and transglutaminase effects on apical growth of the pollen tube 113
Recent advances in the design and synthesis of prazosin derivatives 113
Exploiting RNA as anticancer target for synthetic polyamines 112
Synthesis of monomeric derivatives to probe Memoquin bivalent interactions 109
Polyamine effects on apical growth of the pollen tube 107
null 107
null 106
Interactions between new polyamine analogs and bovine serum amine oxidase. 105
Novel asymmetric naphthalenediimide-polyamines conjugates as anticancer agents. 104
null 104
A kinetic study of new polyamine analogs oxidized by bovine serum amine oxidase . 102
Totale 17.123
Categoria #
all - tutte 52.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.265
Totale 53.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.764 0 59 119 134 164 125 53 138 97 193 347 335
2022/20231.891 219 249 89 224 113 119 101 99 334 60 186 98
2023/20241.004 45 112 78 83 83 193 44 88 55 59 86 78
2024/20252.821 152 348 324 213 563 158 195 115 51 114 134 454
2025/20266.138 589 690 518 412 667 310 895 171 1.068 395 210 213
2026/2027334 136 198 0 0 0 0 0 0 0 0 0 0
Totale 18.880